- Real-world analysis of adherence, persistence, and outcomes in patients receiving four-drug antihypertensive therapy. [Journal Article]Eur Heart J Cardiovasc Pharmacother. 2026 Sep 15. [Online ahead of print]EH
- CONCLUSIONS: In patients receiving four-drug antihypertensive therapy, adherence and persistence were significantly improved with lower pill burden. Persistence was associated with lower risks of CVE and mortality.
- Publisher Full Text (DOI)
- Thiazide Diuretics Are Associated with a Higher Triglyceride-Glucose Index Than Calcium Channel Blockers in Hypertensive Patients. [Journal Article]
- CONCLUSIONS: RAAS blocker plus thiazide/thiazide-like diuretic regimens were associated with a significantly higher TyG index and a less favorable metabolic profile than RAAS blocker plus CCB regimens, independent of multiple clinical confounders. Metabolic risk profiles should be considered when selecting antihypertensive combination therapy; prospective studies are needed to establish causality.
- PMC Free PDF
- Adherence and Healthcare Costs Associated with Single-vs Free-Pill Combination of Perindopril-Based Antihypertensive Medications: An 11-Year Follow-Up, Real-World Evidence. [Journal Article]
- CONCLUSIONS: In this long-term, real-world study, SPC use was associated with better adherence, reduced HCRU, and lower healthcare costs compared with FPC regimens. These economic benefits were evident within 1 year and may yield substantial long-term savings for national health systems, given the high prevalence and chronic nature of hypertension.
- Publisher Full Text (DOI)
- Real-World Effectiveness and Safety of Ramipril/Indapamide Combination Therapy in Essential Hypertension: A Retrospective Study on UK Primary Care Records. [Journal Article]Int J Hypertens. 2026; 2026:1999424.IJ
- CONCLUSIONS: Switching from ramipril or indapamide monotherapy to their free combination was associated with clinically meaningful BP decreases, high adherence and persistence, and a favorable safety profile in routine practice. These findings are consistent with current therapeutic guidelines that endorse its use in essential hypertension management.
- PMC Free PDF
- Impact of the national centralized volume-based procurement policy on antihypertensive drug procurement, price, and volume in Guangxi: an interrupted time series analysis of procurement data. [Journal Article]Front Pharmacol. 2026; 17:1810714.FP
- The impact of China's national centralized volume-based procurement (NVBP) policy on antihypertensive drug procurement in underdeveloped, multi-ethnic regions remains understudied. This study evaluated changes in procurement prices, volumes, and costs for four antihypertensive drugs following the second NVBP batch in Guangxi, an economically disadvantaged region in southwestern China.
- PMC Free PDF
- Urinary Supersaturation in a Randomized Trial Among Individuals with Recurrent Nephrolithiasis Comparing Empiric Versus Selective Preventive Therapy: The URINE Trial. [Journal Article]
- CONCLUSIONS: In this short-term trial among individuals at high risk for stone recurrence, there was no statistically significant difference in the urinary stone risk comparing an empiric vs selective strategy for kidney stone prevention.
- PMC Free PDF
- Baxdrostat (Baxfendy) - an aldosterone synthase inhibitor for hypertension. [Journal Article]Med Lett Drugs Ther. 2026 Jul 06; 68(1758):105-106.ML
- Publisher Full Text (DOI)
- In brief: Widaplik - another three-drug combination for hypertension. [Journal Article]Med Lett Drugs Ther. 2026 Jun 22; 68(1757):101-102.ML
- Publisher Full Text (DOI)
- Drug-Induced Hyponatremia Surveillance: A disproportionality analysis based on FAERs database. [Journal Article]Pak J Med Sci. 2026 Apr; 42(4):848-855.PJ
- CONCLUSIONS: We provide a list of drugs with risk signals for Hyponatremia. In clinical practice, it is helpful to identify the culprit drug early, and prevent it from further aggravation into a serious condition.
- PMC Free PDF
- Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study. [Randomized Controlled Trial]Drug Des Devel Ther. 2026; 20:578736.DD
- CONCLUSIONS: FMS/IND SR combination therapy demonstrated superior antihypertensive efficacy, rapid BP control, and comparable safety to FMS monotherapy. This regimen may serve as an effective therapeutic option, particularly in elderly or high-risk hypertensive patients.
- PMC Free PDF
- An analogue of indapamide: crystal structure and Hirshfeld surface analysis of 3-chloro-4-(N,N-diethynylsulfamo-yl)-N-(2-meth-yl-indolin-1-yl)benzamide. [Journal Article]Acta Crystallogr E Crystallogr Commun. 2026 May 01; 82(Pt 5):454-458.AC
- The title mol-ecule, C22H20ClN3O3S, adopts a shallow cup-shaped conformation with the chloro-benzamide portion as the bottom. A puckering analysis of the five-membered ring indicates an envelope conformation. In the crystal, helical chains along the a-axis direction are formed by N-H⋯O hydrogen bonds reinforced by C-H⋯π(ring) and weak π-stacking inter-actions. No directed inter-actions between ch…
- PMC Free PDF
- Case Report: A reversible autonomic-endothelial migraine pattern: a conceptual perspective illustrated by a clinical case. [Journal Article]Front Pain Res (Lausanne). 2026; 7:1748356.FP
- Migraine is commonly regarded as a primary neurovascular disorder; however, systemic endothelial and autonomic factors may modulate its expression and course. A 41-year-old male with a 10-year history of migraine without aura and vasomotor rhinitis experienced sustained remission after initiation of nebivolol 5 mg and (perindopril 5 mg/indapamide 1.25 mg/amlodipine 5 mg) once daily for mild hyper…
- PMC Free PDF
- Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: win ratio analysis of ADVANCE trial. [Randomized Controlled Trial]
- CONCLUSIONS: The win ratio approach confirms the robustness of the original ADVANCE findings while providing a more detailed understanding of the relative importance of individual outcomes. This method enhances the interpretation and communication of composite endpoint analyses.
- PMC Free PDF
- Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage. [Randomized Controlled Trial]
- CONCLUSIONS: Among patients with intracerebral hemorrhage, treatment with a combination of three low-dose antihypertensive agents in a single pill, in addition to standard care, was associated with a lower incidence of recurrent stroke and major cardiovascular events than placebo. (Funded by the National Health and Medical Research Council of Australia and the Brazilian Ministry of Health; TRIDENT ClinicalTrials.gov number, NCT02699645; Australian New Zealand Clinical Trials Registry number, ACTRN12616000327482.).
- Publisher Full Text (DOI)
- Remnant cholesterol level modified the effects of intensive systolic blood pressure lowering treatment in high-risk hypertensive patients: a post hoc analysis of the ESPRIT trial. [Randomized Controlled Trial]
- We sought to investigate whether remnant cholesterol (RC) modified the effect of intensive blood pressure (BP) lowering treatment. This study was a post hoc analysis of ESPRIT. In this trial, hypertensive patients with high cardiovascular risk were randomly assigned to intensive (systolic BP < 120 mmHg) or standard (systolic BP < 140 mmHg) treatment. Cox regression analysis was used to examine he…
- Publisher Full Text (DOI)